Denise M. Gilbert, Ph.D.
Director
Denise Gilbert has served as a member of our Board and Chair of the Audit Committee since January 2008. Dr. Gilbert is currently an independent consultant and strategic advisor to life science companies. Previously, she served as Chief Executive Officer of Entigen Corporation, a private life science information technology company. In addition, Dr. Gilbert has served as Chief Financial Officer of two public life science companies, Incyte Pharmaceuticals Inc. from 1995 until 1999, and Affymax NV from 1993 until its sale to Glaxo in 1995. Dr. Gilbert started her career in biotechnology in the mid-1980's first in venture capital and then as a senior biotechnology analyst with Smith Barney Harris & Upham and Montgomery Securities. Dr. Gilbert holds a B.A. from Cornell University and a Ph.D. in Cell and Development Biology from Harvard University.